Form D · Other Health Care
Gamma Medica, Inc.
Salem, NH · CIK 0001580867
Offering snapshot reported Oct 14, 2014 · SEC filing
- Reported sold
- $6.5M Offering amount: $6.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $6.5M Reported outside-investor minimum
- First sale
- Sep 30, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 14, 2014 | Initial | $6,500,000 | No comparison | 1 | SEC filing |
| Jul 10, 2013 | Initial | $3,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $65K
- Finders' fees
- $0
- Form D file number
- 021-226371
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Stillpoint Capital, LLC | 133146 | Stillpoint Capital, LLC · CRD 133146 |
Source: Form D, filed Oct 14, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James R. Calandra | Director, Executive |
| David A. Eichler | Director, Executive |
| Christopher Ferrara | Executive |
| Albert S. Waxman | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
12 Manor Parkway Unit 3
Salem, NH, 03079
Salem, NH, 03079